Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
1 Month : From Jul 2019 to Aug 2019
By Chris Wack
Shares of Avalon GloboCare Corp. (AVCO) rose 12% to $2.35 after the company announced a strategic partnership with GE Healthcare.
The clinical-stage global developer of cell-based technologies and therapeutics said the partnership will accelerate Avalon's standardization, automation and bio-production for clinical-grade Chimeric Antigen Receptor cells and other immune-effector cells for cellular immunotherapy.
Both Avalon and GE Healthcare will strategically establish automated and standardized GMP cell production capabilities. Avalon will be given access to GE Healthcare's cell processing expertise and products in the form of FlexFactory Cell Therapy platform, FastTrak process development and training services.
Write to Chris Wack at email@example.com
(END) Dow Jones Newswires
July 23, 2019 09:55 ET (13:55 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.